KREHER NERISSA bought XERS
July 1, 2026 · Form 4 insider transaction
KREHER NERISSA bought 33,582 shares of Xeris Biopharma Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
33,582
Price
$0.00
Total value
N/A
InsiderKREHER NERISSA
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after33,582
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the "Plan"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date.